Treatment of diabetes mellitus: implications of the use of oral agents.
Publication
, Conference
Rao, SV; Bethel, MA; Feinglos, MN
Published in: Am Heart J
November 1999
Duke Scholars
Published In
Am Heart J
DOI
ISSN
0002-8703
Publication Date
November 1999
Volume
138
Issue
5 Pt 1
Start / End Page
S334 / S337
Location
United States
Related Subject Headings
- Survival Rate
- Sulfonylurea Compounds
- Metformin
- Insulin
- Incidence
- Hypoglycemic Agents
- Humans
- Glycated Hemoglobin
- Diabetes Mellitus, Type 2
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Rao, S. V., Bethel, M. A., & Feinglos, M. N. (1999). Treatment of diabetes mellitus: implications of the use of oral agents. In Am Heart J (Vol. 138, pp. S334–S337). United States. https://doi.org/10.1016/s0002-8703(99)70032-3
Rao, S. V., M. A. Bethel, and M. N. Feinglos. “Treatment of diabetes mellitus: implications of the use of oral agents.” In Am Heart J, 138:S334–37, 1999. https://doi.org/10.1016/s0002-8703(99)70032-3.
Rao SV, Bethel MA, Feinglos MN. Treatment of diabetes mellitus: implications of the use of oral agents. In: Am Heart J. 1999. p. S334–7.
Rao, S. V., et al. “Treatment of diabetes mellitus: implications of the use of oral agents.” Am Heart J, vol. 138, no. 5 Pt 1, 1999, pp. S334–37. Pubmed, doi:10.1016/s0002-8703(99)70032-3.
Rao SV, Bethel MA, Feinglos MN. Treatment of diabetes mellitus: implications of the use of oral agents. Am Heart J. 1999. p. S334–S337.
Published In
Am Heart J
DOI
ISSN
0002-8703
Publication Date
November 1999
Volume
138
Issue
5 Pt 1
Start / End Page
S334 / S337
Location
United States
Related Subject Headings
- Survival Rate
- Sulfonylurea Compounds
- Metformin
- Insulin
- Incidence
- Hypoglycemic Agents
- Humans
- Glycated Hemoglobin
- Diabetes Mellitus, Type 2
- Cardiovascular System & Hematology